Abstract and Introduction Abstract. Purpose: The revised prescription drug labeling developed by the Food and Drug Administration (FDA) is described. Summary: A new FDA final rule, "Requirements ...

GLP-1 medications have emerged as a physician-supervised option for individuals managing obesity or weight-related conditions ...